Haopeng Sun

Haopeng Sun

China Pharmaceutical University

H-index: 38

Asia-China

About Haopeng Sun

Haopeng Sun, With an exceptional h-index of 38 and a recent h-index of 33 (since 2020), a distinguished researcher at China Pharmaceutical University, specializes in the field of Medicinal Chemistry, Molecular Design, Computer-aided Drug Design, Pharmacology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Optimizing drug-like properties of selective butyrylcholinesterase inhibitors for cognitive improvement: Enhancing aqueous solubility by disrupting molecular plane

Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for In Vivo Theranostics of Alzheimer’s Disease

Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors

Direct Synthesis of α-and β-2′-Deoxynucleosides with Stereodirecting Phosphine Oxide via Remote Participation

Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase …

Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's Disease

Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer

Medicinal prospects of targeting tyrosinase: A feature review

Haopeng Sun Information

University

Position

___

Citations(all)

5167

Citations(since 2020)

4078

Cited By

2525

hIndex(all)

38

hIndex(since 2020)

33

i10Index(all)

119

i10Index(since 2020)

99

Email

University Profile Page

China Pharmaceutical University

Google Scholar

View Google Scholar Profile

Haopeng Sun Skills & Research Interests

Medicinal Chemistry

Molecular Design

Computer-aided Drug Design

Pharmacology

Top articles of Haopeng Sun

Title

Journal

Author(s)

Publication Date

Optimizing drug-like properties of selective butyrylcholinesterase inhibitors for cognitive improvement: Enhancing aqueous solubility by disrupting molecular plane

European Journal of Medicinal Chemistry

Shuaishuai Xing

Xu Tang

Jun Wang

Bingbing Lv

Xiaolong Wang

...

2024/3/2

Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for In Vivo Theranostics of Alzheimer’s Disease

Journal of Medicinal Chemistry

Lei Wang

Tianyu Sun

Tengfei Zhen

Wei Li

Huajing Yang

...

2024/3/28

Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors

Bioorganic & medicinal chemistry

Ana R Gomes

Ana S Pires

Ana M Abrantes

Ana C Goncalves

Saul C Costa

...

2021/9/15

Direct Synthesis of α-and β-2′-Deoxynucleosides with Stereodirecting Phosphine Oxide via Remote Participation

Journal of the American Chemical Society

Xintong Tang

Yueer Zhou

Yingjie Wang

Yetong Lin

Shuheng Pan

...

2024/3/14

Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase …

ACS Chemical Neuroscience

Xin Lu

Yueqing Li

Qianwen Guan

Huajing Yang

Yijun Liu

...

2024/3/7

Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's Disease

European Journal of Medicinal Chemistry

Ying Chen

Weiting Zhang

Qi Li

Huanfang Xie

Shuaishuai Xing

...

2024/4/30

Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer

European journal of medicinal chemistry

Yang Liu

Yuting Chen

Jiheng Jiang

Xianglin Chu

Qinglong Guo

...

2023/2/5

Medicinal prospects of targeting tyrosinase: A feature review

Yuanyuan Wang

Baichen Xiong

Shuaishuai Xing

Ying Chen

Qinghong Liao

...

2023/7/1

Inhibition of Son of Sevenless Homologue 1 (SOS1): Promising therapeutic treatment for KRAS-mutant cancers

Tingkai Chen

Xu Tang

Zhenqi Wang

Feng Feng

Chunlei Xu

...

2023/9/25

Discovery of potent and wild-type-sparing fourth-generation EGFR Inhibitors for treatment of osimertinib-resistance NSCLC

Journal of Medicinal Chemistry

Haojie Dong

Xiuquan Ye

Yasheng Zhu

Hao Shen

Hongtao Shen

...

2023/5/4

Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment

Journal of Medicinal Chemistry

Siyu He

Xianglin Chu

Yujia Wu

Jiheng Jiang

Pengfei Fang

...

2023/7/6

Discovery of thiazole salt AChE inhibitors and development of thiamine disulfide prodrugs targeting the central nervous system

Bioorganic Chemistry

Chang Liu

Manxing Zou

Jianguo Zuo

Huanfang Xie

Weiping Lyu

...

2023/10/1

Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement

Xuemei Wei

Guoqi Yu

Hualiang Shen

Yanjuan Luo

Tianbo Shang

...

2023/1/1

Selective Butyrylcholinesterase Inhibitor or Pharmaceutically Acceptable Salt Thereof, Preparation Method and Use Thereof

2023/6/1

The structural modification and biological evaluation of tetrahydrothienopyridine derivatives as selective BChE inhibitors

Bioorganic & Medicinal Chemistry Letters

Tingkai Chen

Shenghu Sang

Yuqing Wei

Yujie Ge

Jisheng Jin

...

2023/9/1

The development and design strategy of leucine-rich repeat kinase 2 inhibitors: promising therapeutic agents for Parkinson’s disease

Xu Tang

Shuaishuai Xing

Mingkang Ma

Ziwei Xu

Qianwen Guan

...

2023/2/9

Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds

Weimin Qiu

Hui Liu

Yijun Liu

Xin Lu

Lei Wang

...

2023/7

Identification of a Novel, Potent, and Orally Bioavailable Guanidine-Based SHP2 Allosteric Inhibitor from Virtual Screening and Rational Structural Optimization for the …

Journal of Medicinal Chemistry

Qiangqiang Hou

Wenhua Jiang

Wenqiang Li

Chenyang Huang

Kexin Yang

...

2023/9/27

Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases

Hualiang Shen

Xinde Xu

Yalong Bai

Xiaoping Wang

Yibin Wu

...

2023/5/5

Design, Synthesis, and Proof of Concept of Balanced Dual Inhibitors of Butyrylcholinesterase (BChE) and Histone Deacetylase 6 (HDAC6) for the Treatment of Alzheimer’s Disease

ACS Chemical Neuroscience

Lei Wang

Tianyu Sun

Zhenqi Wang

Hui Liu

Weimin Qiu

...

2023/8/10

See List of Professors in Haopeng Sun University(China Pharmaceutical University)